Back
Day One Biopharmaceuticals 10K Form
Buy
54
DAWN
Day One Biopharmaceuticals
Last Price:
16.18
Seasonality Move:
124.22%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive DAWN News And Ratings
See the #1 stock for the next 7 days that we like better than DAWN
DAWN Financial Statistics
Sales & Book Value
Annual Sales: | -- |
---|---|
Cash Flow: | $-49.73M |
Price / Cash Flow: | 0 |
Annual Sales: | $3.40 |
Price / Book: | 4.76 |
Profitability
EPS (TTM): | -2.51000 |
---|---|
Net Income (TTM): | $-208.94M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | 0% |
Day One Biopharmaceuticals Earnings Forecast
Key Day One Biopharmaceuticals Financial Ratios
- The Interest Expense is -0.07% of Operating Income.
- Per Share Earnings over the last 5 years have been positive in 1 years.
Day One Biopharmaceuticals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | DAWN |
Website: | dayonebio.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
DAWN Technical Analysis vs Fundamental Analysis
Buy
54
Day One Biopharmaceuticals (DAWN)
is a Buy
Is Day One Biopharmaceuticals a Buy or a Sell?
-
Day One Biopharmaceuticals stock is rated a Buy
The current Day One Biopharmaceuticals [DAWN] share price is $16.17. The Score for DAWN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.